- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Trastuzumab antibody from different biosimilar commercial drugs.
Showing all 6 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
HER2 |
Biosimilar , Monoclonal Antibody |
Herzuma® |
21 mg/mL |
– |
6 mg |
tba |
tba |
356,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Ontruzant® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Kanjinti® |
21 mg/mL |
– |
6 mg |
-80°C |
2025.01 |
367,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Zercepac® |
21 mg/mL |
– |
6 mg |
-80°C |
2026.08 |
367,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Ogivri® |
21 mg/mL |
– |
6 mg |
-80°C |
2025.10 |
451,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Trazimera® |
21 mg/mL |
– |
2 mg |
-80 °C |
2026.09 |
164,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany